Earnings call transcript: FiscalNote Holdings Q1 2026 sees revenue decline

FiscalNote reported Q1 2026 revenue of $20 million, in line with guidance, but posted a $43.6 million GAAP net loss driven by a $35.6 million goodwill impairment charge. ARR fell to $75.7 million from $84.1 million and net revenue retention dropped to 89%, signaling customer attrition despite management reaffirming full-year revenue of $80 million-$83 million and adjusted EBITDA of $14 million-$16 million. The company highlighted restructuring, a completed PolicyNote migration, and new API/prediction-market initiatives, while shares remained flat premarket after closing at $0.205.

Analysis

The key issue is not the headline revenue print; it is the widening gap between operational simplification and customer economics. The platform migration can improve product coherence and lower servicing costs, but the near-term risk is that consolidation is also forcing a hard reset of the customer base, leaving the company more dependent on a smaller number of renewals and a narrower set of buyers. That makes the retention trend more important than the absolute revenue guide, because any further slippage could cause a step-function impairment to 2026 credibility even if management continues to hit the low end of targets.

The balance-sheet and capital-structure setup is the real overhang. At this size, the equity is effectively a residual claim on a deleveraging story, and any debt negotiation friction can dominate operating progress for months. The move to OTC may reduce immediate listing risk, but it also keeps the stock in a low-liquidity regime where even modest fundamental disappointment can create outsized downside. In other words, the path to a rerating is not just execution; it requires a cleaner creditor outcome and evidence that the post-migration cohort is actually monetizing better, not just surviving.

The market may be underestimating how much of the “AI” narrative is still optionality rather than realized revenue. API and agentic workflow adoption are plausible long-dated upside vectors, but they are unlikely to offset retention pressure over the next 1-2 quarters unless conversion from signups to paid usage accelerates quickly. The contrarian angle is that the current equity price already discounts severe distress, so the stock can bounce hard on any incremental proof point; however, that is a trading dynamic, not an investable fundamental thesis until cash flow and refinancing visibility improve.

Near term, the highest-probability catalyst is guidance commentary on Q2 sequential stabilization and the first evidence that the migration lifts gross or net retention. If that does not show up by the next print, the market will likely reprice this as a slow bleed turnaround with financing risk attached. The upside scenario requires both improving retention and a credible debt solution; without both, rallies should be treated as liquidity-driven rather than durable.

Key Decisions for Investors

• Avoid outright long exposure to NOTE until there is evidence of sequential ARR stabilization; the risk/reward remains asymmetric to the downside if retention weakens further over the next 1-2 quarters.
• For existing holders, sell upside calls against the position into any post-earnings bounce; the stock is likely to trade as a volatility instrument rather than a fundamental compounder until refinancing risk clears.
• Consider a tactical short in NOTE on strength if price action disconnects from operating data; the setup favors 3-6 month downside if Q2 does not show clear retention improvement.
• If you want exposure to the policy-intelligence/AI theme, prefer a higher-quality software proxy with recurring growth and no balance-sheet overhang rather than NOTE; the optionality is cleaner elsewhere.
• Set a catalyst window around the next quarterly update: only revisit long exposure if management shows sequential revenue stabilization plus a credible creditor resolution path, which would materially improve the risk/reward over a 6-12 month horizon.